| Leslie Jones, SLP | |
|
735 Glynn St S Ste 201, Fayetteville, GA 30214-2049 | |
| (770) 856-5917 | |
| (770) 716-3266 |
| Full Name | Leslie Jones |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 735 Glynn St S Ste 201, Fayetteville, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225153471 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP005501 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Leslie Jones, SLP 735 Glynn St S Ste 201, Fayetteville, GA 30214-2049 Ph: (770) 856-5917 | Leslie Jones, SLP 735 Glynn St S Ste 201, Fayetteville, GA 30214-2049 Ph: (770) 856-5917 |
News Archive
There has been little research on the mechanism of action of "magic mushrooms" on the brain. A growing number of studies suggested that perhaps the mushrooms' key ingredient could work magic for certain mental disorders. New research in Proceedings of the National Academy of Sciences sheds light on why one of the mushrooms' hallucinogenic chemical compounds, psilocybin, may hold promise for the treatment of depression.
Neurologix, Inc., a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced that the U.S. Patent and Trademark Office (US PTO) has expanded the intellectual property protections enabled by a previously issued patent that is central to Neurologix's Parkinson's disease program. The new allowances to U.S. Patent Number 765,446, entitled "Glutamic acid decarboxylase (GAD) based delivery systems," broaden the patent's coverage beyond Parkinson's disease to include the use of GAD65 in the treatment of other neurological and related disorders.
Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry, announced today that it has signed an expanded contract manufacturing agreement with Merck & Co., Inc. (known as MSD outside of the U.S.A. and Canada).
A remarkable story of how a new disease was inadvertently caused by successful medical treatment, ultimately understood, and eventually defeated by scientific innovation is being told a major player in the process.
› Verified 3 days ago
Mrs. Linda H Radcliffe, MSP, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Devant St, Suite 703, Fayetteville, GA 30214 Phone: 770-776-6013 Fax: 877-469-5558 | |
Desia Bradley-griffin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Bradford Sq Ste A, Fayetteville, GA 30215 Phone: 770-703-6935 | |
Christina Merman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 290 Brandywine Blvd, Fayetteville, GA 30214 Phone: 770-460-0165 Fax: 770-460-0189 | |
Denise Lynn Fye, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 269 Grooms Rd, Fayetteville, GA 30215 Phone: 404-725-3182 | |
Agape Speech Therapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Devant St, Suite 703, Fayetteville, GA 30214 Phone: 770-776-6013 Fax: 877-469-5558 | |
Elisabeth Pleasant, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 175 Carnegie Pl Ste 137, Fayetteville, GA 30214 Phone: 770-719-8840 | |
Rita Horton, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 130 Howard Ln, Fayetteville, GA 30215 Phone: 770-460-0165 |